Loading
No description yet: the sentence for this tag has not been written. 2 records carry it: 2 drugs.
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
CIMAvax-EGF CIMAvax-EGF CIMAvax-EGF is a Cuban vaccine for advanced non-small cell lung cancer, given after chemotherapy so the body blocks a growth signal the tumour uses. Cuba registered it in 2008. In its phase III trial the survival gain was not significant by the standard test, but was by a weighted test and among patients given at least four doses. It is not approved in the United States or the European Union. | Established | Non-small-cell lung cancer | cancer-vaccine | ||
Racotumomab Vaxira Racotumomab (Vaxira) is a Cuban vaccine for advanced non-small cell lung cancer, given after first-line treatment to patients whose cancer has responded or held steady. In a placebo-controlled trial of 176 patients it lengthened median survival from 6.8 to 8.2 months. It is registered in Cuba and is not approved in the United States or the European Union. | Established | Non-small-cell lung cancer | cancer-vaccine |